Glutathione Blood Work Labs — What to Check Before & After

Most glutathione supplementation protocols fail at the measurement stage. Not the dosing stage. Patients start oral or IV glutathione expecting antioxidant benefits, immune support, or liver detoxification without ever establishing a baseline. Three months later, they're evaluating efficacy based on subjective energy levels or skin tone rather than objective biomarkers. The single biggest predictor of successful glutathione therapy isn't the route of administration or the dose. It's whether the patient tracked glutathione status through proper blood work before starting and at defined intervals afterward.

Our team has worked with research facilities running controlled glutathione protocols for years. The gap between anecdotal supplement use and evidence-based intervention comes down to one thing: measurement. If you can't quantify baseline glutathione status and track changes over time, you have no way to distinguish a physiological response from placebo or to identify non-responders before they waste months on ineffective protocols.

What blood work should I order to measure glutathione levels accurately?

Glutathione blood work requires measurement of three biomarkers: reduced glutathione (GSH), oxidized glutathione (GSSG), and the GSH:GSSG ratio. Baseline levels in healthy adults range from 800–1200 μmol/L for total glutathione in whole blood, with the GSH:GSSG ratio typically above 100:1. Measuring only total glutathione without distinguishing reduced from oxidized forms misses the functional antioxidant capacity entirely.

The confusion around glutathione testing stems from the fact that most standard metabolic panels don't include it. Glutathione is not part of a CBC, CMP, or lipid panel. It requires a specialized redox or antioxidant marker panel ordered through functional medicine labs like Genova Diagnostics, Doctor's Data, or LabCorp's specialty oxidative stress profile. Baseline testing before supplementation establishes whether you're starting from normal, depleted, or severely oxidized status. Which determines dosing strategy, route of administration, and realistic outcome timelines. This article covers exactly which markers matter, what the reference ranges mean, how pre- and post-supplementation testing should be timed, and what interpretation errors cause most glutathione protocols to fail.

The Three Core Glutathione Markers You Must Measure

Glutathione exists in two forms in the body: reduced glutathione (GSH), the active antioxidant form, and oxidized glutathione (GSSG), the spent form that accumulates under oxidative stress. Measuring only 'total glutathione'. The sum of GSH and GSSG. Tells you almost nothing about functional antioxidant capacity. A patient could have normal total glutathione but a severely unfavorable GSH:GSSG ratio, indicating high oxidative stress despite adequate synthesis.

Reduced glutathione (GSH) is the metric that matters for antioxidant activity. It directly scavenges reactive oxygen species, regenerates vitamins C and E, and supports Phase II detoxification in the liver. Normal whole blood GSH ranges from 800–1200 μmol/L in healthy adults. Values below 600 μmol/L indicate depletion that warrants intervention. Oxidized glutathione (GSSG) accumulates when GSH is consumed faster than it can be regenerated by glutathione reductase. The enzyme that recycles GSSG back to GSH using NADPH as a cofactor. Elevated GSSG (above 20 μmol/L in whole blood) signals that the antioxidant system is overwhelmed.

The GSH:GSSG ratio is the most clinically meaningful marker. A healthy ratio is typically above 100:1. Meaning for every molecule of oxidized glutathione, there are at least 100 molecules of reduced glutathione available. Ratios below 50:1 indicate oxidative stress. Ratios below 10:1 suggest severe depletion that oral supplementation alone is unlikely to reverse without addressing upstream enzymatic cofactors like riboflavin, niacin, and selenium.

Baseline Testing: When and Why It Matters

Baseline glutathione testing should occur before starting any supplementation protocol. Ideally two to four weeks before the first dose to avoid interference from recent supplement use or dietary changes. This establishes your starting redox status and determines whether supplementation is even indicated. Patients with normal GSH levels (above 900 μmol/L) and favorable ratios (above 100:1) may not benefit meaningfully from additional glutathione. Their synthesis pathways are already functioning optimally.

Sample collection timing matters more than most labs acknowledge. Glutathione levels fluctuate throughout the day based on meal timing, exercise, and circadian rhythm. Fasting morning samples provide the most consistent baseline. Instruct the lab to process whole blood samples within two hours of collection, as glutathione degrades rapidly at room temperature. Delayed processing or improper storage (samples left at room temperature for more than four hours) can underestimate GSH by 30–50%.

Our experience working with research peptide protocols has shown that patients who skip baseline testing waste an average of 8–12 weeks on interventions that were never appropriate for their redox status in the first place. If your baseline GSH is already 1100 μmol/L, adding 500mg oral glutathione daily won't move the needle. You're supplementing a non-deficiency. Conversely, patients with severe depletion (GSH below 400 μmol/L) often require IV protocols or liposomal formulations that baseline testing would have identified from the start.

Glutathione Blood Work Labs: Comparison of Testing Panels

| Lab Provider | Test Name | Markers Included | Sample Type | Turnaround | Typical Cost | Professional Assessment |
|—|—|—|—|—|—|
| Genova Diagnostics | Oxidative Stress 2.0 | GSH, GSSG, GSH:GSSG ratio, lipid peroxides, 8-OHdG | Whole blood + urine | 10–14 days | $300–$400 | Most comprehensive panel. Includes downstream oxidative damage markers that contextualize glutathione depletion |
| Doctor's Data | Glutathione Profile | GSH, GSSG, ratio only | Whole blood | 7–10 days | $180–$220 | Focused, cost-effective option if you only need core glutathione markers without broader oxidative stress context |
| LabCorp (Specialty) | Antioxidant Panel | Total glutathione, GSH, GSSG, vitamins C/E | Serum | 5–7 days | $250–$320 | Faster turnaround but serum testing underestimates intracellular glutathione compared to whole blood methods |
| ZRT Laboratory | Cellular Oxidative Stress | GSH, CoQ10, vitamin D, hs-CRP | Dried blood spot | 7–10 days | $200–$280 | Convenient at-home collection but dried blood spot methodology has higher variability than venous whole blood |

The Genova Diagnostics Oxidative Stress 2.0 panel remains the gold standard for glutathione assessment because it measures not just glutathione status but also downstream markers of oxidative damage. Lipid peroxidation (F2-isoprostanes) and DNA oxidation (8-hydroxy-2'-deoxyguanosine). This allows you to correlate low glutathione with actual oxidative injury rather than assuming depletion equals pathology.

Post-Supplementation Testing: Timing and Interpretation

Post-supplementation glutathione testing should occur 8–12 weeks after starting a protocol. Not earlier. Oral glutathione formulations take 6–8 weeks to reach steady-state tissue concentrations, and testing at week 3 or 4 captures transient absorption spikes rather than sustained intracellular elevation. IV glutathione protocols can be retested at 4–6 weeks because bioavailability is immediate, but even then, the goal is sustained elevation. Not peak levels measured 48 hours post-infusion.

Interpret post-supplementation results relative to baseline. Not just reference ranges. A patient whose GSH increased from 650 μmol/L to 850 μmol/L shows a meaningful response even though both values fall within the 'normal' range of 600–1200 μmol/L. Conversely, a patient who started at 1100 μmol/L and retests at 1150 μmol/L after three months of oral supplementation has demonstrated no clinically significant change. The protocol added cost without measurable benefit.

The GSH:GSSG ratio is the most sensitive marker of protocol efficacy. A patient whose ratio improved from 40:1 to 90:1 has demonstrated reduced oxidative stress regardless of whether absolute GSH levels changed dramatically. If the ratio worsens or remains unchanged despite rising total glutathione, it suggests that supplementation is increasing both GSH and GSSG proportionally. A sign that the underlying oxidative stressor hasn't been addressed. This pattern appears frequently in patients supplementing glutathione while continuing high-dose alcohol, chronic NSAID use, or uncontrolled hyperglycemia.

Key Takeaways

• Glutathione blood work must measure reduced glutathione (GSH), oxidized glutathione (GSSG), and the GSH:GSSG ratio. Total glutathione alone is insufficient for assessing antioxidant capacity.
• Baseline whole blood GSH levels in healthy adults range from 800–1200 μmol/L, with a GSH:GSSG ratio above 100:1 indicating optimal redox status.
• Sample timing and processing matter. Fasting morning samples processed within two hours provide the most accurate baseline, as glutathione degrades rapidly at room temperature.
• Post-supplementation testing should occur 8–12 weeks after starting oral protocols (4–6 weeks for IV protocols) to capture sustained tissue-level changes rather than transient absorption spikes.
• A worsening GSH:GSSG ratio despite rising total glutathione indicates that supplementation is ineffective without addressing the upstream oxidative stressor driving glutathione consumption.

What If: Glutathione Testing Scenarios

What If My Baseline Glutathione Is Already Normal?

Don't supplement just because the compound has theoretical benefits. If your baseline GSH is above 900 μmol/L and your GSH:GSSG ratio is above 100:1, your endogenous synthesis pathways are functioning optimally. Adding exogenous glutathione won't improve an already-sufficient system. Redirect resources toward maintaining cofactor status (selenium, riboflavin, glycine) rather than forcing additional substrate into a pathway that's already saturated. The exception: acute oxidative challenges like chemotherapy, radiation exposure, or acetaminophen overdose create temporary depletion that warrants short-term intervention regardless of baseline.

What If My Post-Supplementation Labs Show No Change?

First, verify that the supplementation route and formulation support bioavailability. Standard oral glutathione capsules are degraded by gastric acid and intestinal peptidases. Serum levels often don't budge despite consistent dosing. Liposomal formulations, sublingual preparations, or IV administration bypass first-pass metabolism and demonstrate measurably higher tissue uptake. Second, assess whether the testing interval was adequate. Retesting at week 4 of an oral protocol captures incomplete tissue saturation. Third, investigate whether cofactor deficiencies (B2, B3, selenium, NAC precursors) are limiting endogenous synthesis despite adequate glutathione intake. Non-response to supplementation often indicates enzymatic bottlenecks, not dosing inadequacy.

What If My GSH:GSSG Ratio Worsened After Supplementation?

A worsening ratio despite supplementation indicates that oxidative stress is consuming glutathione faster than you're replenishing it. The intervention is treating the symptom, not the cause. Common culprits: uncontrolled diabetes (hyperglycemia-driven ROS production), chronic alcohol use (acetaldehyde metabolism depletes GSH), mitochondrial dysfunction (impaired NADPH regeneration limiting glutathione reductase activity), or ongoing xenobiotic exposure (heavy metals, pesticides, pharmaceutical agents). Address the oxidative driver first. Supplementation alone can't outpace continuous depletion.

The Blunt Truth About Glutathione Blood Work

Here's the honest answer: most people supplementing glutathione have never measured it. Not before starting. Not after months of daily dosing. They're operating on testimonials, influencer recommendations, and theoretical mechanisms without ever confirming that the intervention moved a single biomarker. Glutathione is one of the most overhyped, under-measured supplements in functional medicine. Patients spend thousands on liposomal formulations, IV infusions, and precursor stacks without ever asking the one question that matters: did my GSH level or GSH:GSSG ratio actually improve?

If you're not willing to test, don't supplement. The cost of baseline and follow-up testing ($300–$500 total) is less than three months of high-quality glutathione products. And it's the only way to distinguish responders from non-responders before wasting time and money on ineffective protocols. Real optimization requires measurement.

Glutathione matters. Oxidative stress is real, Phase II detoxification depends on it, and certain patient populations (chronic illness, toxin exposure, mitochondrial disorders) genuinely benefit from therapeutic intervention. But the gap between anecdotal use and evidence-based therapy is blood work. Without it, you're guessing. Supplementation without measurement is hope, not medicine.

If glutathione blood work labs reveal depletion, targeted supplementation combined with cofactor support can restore redox balance within 8–12 weeks. Provided you retest to confirm the response. If baseline labs show normal status, redirect resources toward the upstream factors that maintain synthesis: adequate protein intake (glycine, cysteine, glutamate), selenium sufficiency, and mitochondrial health. And if post-supplementation labs show no improvement despite months of intervention, it's time to investigate enzymatic cofactors, absorption barriers, or whether the oxidative stressor driving depletion was ever addressed in the first place.